Murine interleukin-12 prevents the development of cancer cachexia in a murine model

International Journal of Cancer

Volumn 67, Issue 6, 1996, Pages 849-855

  Mori, Kazushige ^a   Fujimoto Ouchi, Kaori ^a   Ishikawa, Tohru ^a   Sekiguchi, Fumiko ^a   Ishitsuka, Hideo ^a   Tanaka, Yutaka ^a  

^a NIPPON ROCHE RESEARCH CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 6; RECOMBINANT INTERLEUKIN 1ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CACHEXIA; COLON CARCINOMA; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; BODY WEIGHT; CACHEXIA; COLONIC NEOPLASMS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; MICE, NUDE; NEOPLASMS, EXPERIMENTAL;

EID: 0029910826     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960917)67:6<849::AID-IJC15>3.0.CO;2-X     Document Type: Article

References (35)

1. BLACK, K., GARRETT, R. and MUNDY, G.R., Chinese hamster ovarian cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude mice. Endocrinology, 128, 2657-2659 (1991).
2. BRUNDA, M.J., Interleukin-12. J. Leukocyte Biol., 55, 280-288 (1994).
3. BRUNDA, M.J., LUISTRO, L., WARRIER, R.R., WRIGHT, R.B., HUBBARD, B.R., MURPHY, M., WOLF, S.F. and GATELY, M.K., Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. exp. Med., 178, 1223-1230 (1993).
4. DEWYS, W.D. and 19 OTHERS, Prognostic effect of weight loss prior to chemotherapy in cancer patients. Amer. J. Med., 69, 491-497 (1980).
5. DEWYS, W.D., BEGG, C., BAND, P. and TORMEY, D., The impact of malnutrition on treatment in breast cancer. Cancer Treat. Rep., 65(suppl. 5), 87s-91s (1981).
6. FIORENTINO, D.F., BOND, M.W. and MOSMANN, T.R., Two types of mouse helper T cells. IV. Th2 clones secrete a factor that inhibits cytokine-production by Th1 clones. J. exp. Med., 170, 2081-2095 (1989).
7. GATELY, M.K. and CHIZZONITE, R., Measurement of human and mouse interleukin 12. In: J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach and W. Strober (eds.), Current protocols in immunology, Vol. 1, Wiley, New York (1992).
8. GELIN, J., MOLDAWER, L.L., LONNROTH, C., SHERRY, B., CHIZZONITE, R. and LUNDHOLM, K., Role of endogenous tumor necrosis factor α and interleukin 1 for experimental tumor growth and the development of cancer cachexia. Cancer Res., 51, 415-421 (1991).
9. GERMANN, T., GATELY, M.K., SCHOENHAUT, D.S., LOHOFF, M., MATTNER, F., FISCHER, S., JIN, S.-C., SCHMIT, E. and RUDE, E., Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells. Europ. J. Immunol., 23, 1762-1770 (1993).
10. HYLTANDER, A., WARNOLD, I., EDEN, E. and LUNDHOLM, K., Effect on whole-body protein synthesis after institution of intravenous nutrition in cancer and non-cancer patients who lose weight. Europ. J. Cancer, 27, 16-21 (1991).
11. KOBAYASHI, M., FITZ, L., RYAN, M., HEWICK, R.M., CLARK, S.C., CHAN, S., LOUDON, R., SHERMAN, F., PERUSSIA, B. and TRINCHIERI, G., Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J exp. Med., 170, 827-845 (1989).
12. + T-cell function. Jap. J. Cancer Res., 84, 315-325 (1993).
13. MATTHYS, P., DIJKMANS, R., PROOST, P., VAN DAMME, J., HEREMANS, H., SOBIS, H. and BILLIAU, A., Severe cachexia in mice inoculated with interferon-γ-producing tumor cells. Int. J. Cancer, 49, 77-82 (1991a).
14. MATTHYS, P., HEREMANS, H., OPDENAKKER, G. and BILLIAU, A., Anti-interferon-γ antibody treatment, growth of Lewis lung tumors in mice and tumor-associated cachexia. Europ. J. Cancer, 27, 182-187 (1991b).
15. MORI, M., YAMAGUCHI, K., HONDA, S., NAGASAKI, K., UEDA, M., ABE, O. and ABE, K., Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor. Cancer Res., 51, 6656-6659 (1991).
16. MOSSMANN, T.R. and COFFMAN, R.L., Heterogeneity of cytokine secretion patterns and functions of helper T cells. Advanc. Immunol., 46, 111-147 (1989).
17. NORTON, J.A., PEACOCK, J.L. and MORRISON, S.D., Cancer cachexia. CRC Crit. Rev Oncol. Hematol., 7, 289-327 (1987).
18. OHE, Y., PODACK, E.R., OLSEN, K.J., MIYAHARA, Y., MIURA, K., SAITO, H., KOISHIHARA, Y., OHSUGI, Y., OHIRA, T., NISHIO, K., and SAIJO, N., Interleukin-6 cDNA transfected Lewis lung carcinoma cells show unaltered net tumor growth rate but cause weight loss and shorten survival in syngenic mice. Brit. J. Cancer, 67, 939-944 (1993).
19. OLDENBURG, H.S.A., ROGY, M.A., LAZARUS, D.D., VAN ZEE, K.J., KEELER, B.P., CHIZZONITE, R.A., LOWRY, S.F. and MOLDAWER, L.L., Cachexia and the acute-phase protein response in inflammation are regulated by interleukin-6. Europ. J. Immunol., 23, 1889-1894 (1993).
20. OLIFF, A., DEFEO-JONES, D., BOYER, M., MARTINEZ, D., KIEFER, D., VUOCOLO, G., WOLFE, A. and SOCHER, S.H., Tumors secreting human TNF/cachectin induce cachexia in mice. Cell, 50, 555-563 (1987).
21. OUCHI, K.F., TAMURA, S., MORI, K., TANAKA, Y. and ISHITSUKA, H., Establishment and characterization of cachexia-inducing and -non-inducing clones of murine colon 26 carcinoma. Int. J. Cancer, 61, 522-528 (1995).
22. POWRIE, F. and COFFMAN, R.L., Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol. Today, 14, 270-274 (1993).
23. SCHOENHAUT, D.D., CHUDA, A.O., WOLITZKY, A.G., QUINN, P.M., DWYER, CM., MCCOMAS, W., FAMILLETTI, P.C., GATELY, M.K. and GUBLER, U., Cloning and expression of murine IL-12. J. Immunol., 148, 3433-3440 (1992).
24. SHERRY, B.A., GELIN, G., FONG, Y., MARANO, M., WEI, H., CERAMI, A., LOWRY, S.F., LUNDHOLM, K.G. and MOLDAWER, L.L., Anticachectin/tumor necrosis factor-α antibodies attenuate development of cachexia in tumor models. FASEB J., 3, 1956-1962 (1989).
25. SHIBATA, Y., TAMURA, K. and ISHIDA, N., In vivo analysis of the suppressive effects of immunosuppressive acidic protein, a type of α 1-acid glycoprotein, in connection with its high level in tumor-bearing mice. Cancer Res., 43, 2889-2896 (1983).
26. STERN, A.S., PODLASKI, F.J., HULMES, J.D., PAN, Y.E., QUINN, P.M., WOLITZKY, A.G., FAMILLETTI, P.C., STREMLO, D.L., TRUITT, T., CHIZZONITE, R. and GATELY, M.K., Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. nat. Acad. Sci. (Wash.), 87, 6808-6812 (1990).
27. STRASSMANN, G., FONG, M., KENNEY, J.S. and JACOB, C.O., Evidence for involvement of interleukin 6 in experimental cancer cachexia. J. clin. Invest., 89, 1681-1684 (1992).
28. SULITZEANU, D., Immunosuppressive factors in human cancer. Advanc. Cancer Res., 60, 247-267 (1993).
29. TAMURA, S., OUCHI, K.F., MORI, K., ENDO, M., MATSUMOTO, T., EDA, H., TANAKA, Y., ISHITSUKA, H., TOKITA, H. and YAMAGUCHI, K., Involvement of human interleukin 6 in experimental cachexia induced by a human uterine cervical carcinoma xenograft. Clin. Cancer Res., 1, 1353-1358 (1995).
30. TANAKA, Y., EDA, H., FUJIMOTO, K., TANAKA, T., ISHIKAWA, T. and ISHITSUKA, H., Anticachectic activity of 5'-deoxy-5-fluorouridine in a murine tumor cachexia model, colon 26 adenocarcinoma. Cancer Res., 50, 4528-4532 (1990a).
31. TANAKA, Y., EDA, H., TANAKA, T., UDAGAWA, T., ISHIKAWA, T., HORII, I. and ISHITSUKA, H., Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice. Cancer Res., 50, 2290-2295 (1990b).
32. TANAKA, Y., TANAKA, T. and ISHITSUKA, H., Antitumor activity of indomethacin in mice bearing colon 26 carcinoma compared with those with early transplants. Cancer Res., 49, 5935-5939 (1989).
33. TISDALE, M.J., Cancer cachexia. Brit. J. Cancer, 63, 337-342 (1991).
34. TRINCHIERI, G., Interleukin-12 and its role in the generation of Th1 cells. Immunol. Today, 14, 335-338 (1993).
35. ZUGMAIER, G., PAIKS, S., WILDING, G., KNABBE, C., BANO, M., LUPU, R., DESCHAUNER, B., SIMPSON, S., DICKSON, R.B. and LIPPMANN, M., Transforming growth factor β1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice. Cancer Res., 51, 3590-3594 (1991).